Type 2 diabetes trials in United Kingdom
20 of 62 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleReal-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
- Where
- Birmingham, London
- People
- 60 worldwide
- Run by
- Sanofi
See details and how to joinNCT07457580 - No phaseTaking peopleA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Where
- Edinburgh, London
- Age
- 18 years to 99 years
- People
- 24,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05663515 - No phaseTaking peopleBenefits of Retained Insulin for Good Health
- Where
- Bath, Bristol, Exeter, Truro
- Age
- 18 years and over
- People
- 700
- Run by
- Royal Devon and Exeter NHS Foundation Trust
See details and how to joinNCT07828626 - No phaseNot yet taking people in United KingdomImplementation of Networked Continuous Glucose Monitoring With Telemetry Within the Intensive Care Unit (ICU-TeleCGM)
- Where
- London
- Age
- 18 years and over
- People
- 70
- Run by
- Imperial College Healthcare NHS Trust
See details and how to joinNCT07769138 - No phaseTaking peopleManganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction
- Where
- Leicester
- Age
- 18 years and over
- People
- 60
- Run by
- University of Leicester
See details and how to joinNCT06652763 - No phaseTaking peopleCapillary OGTT Study
- Where
- Cardiff, London, Nottingham, Oxford
- Age
- Up to 17 years
- People
- 135
- Run by
- University of Oxford
See details and how to joinNCT06815081 - No phaseEnrolling by invitationA Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters
- Where
- Glasgow
- Age
- Up to 18 years
- People
- 500
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06709040 - No phaseEnrolling by invitationPDE3B in Metabolic Regulation
- Where
- Cambridge
- Age
- 21 years to 75 years
- People
- 40
- Run by
- Cambridge University Hospitals NHS Foundation Trust
See details and how to joinNCT06533007 - No phaseEnrolling by invitationSweet Sensing in Type 2 Diabetes
- Where
- Nottingham
- Age
- 18 years to 60 years
- People
- 505
- Run by
- University of Nottingham
See details and how to joinNCT06804187 - No phaseTaking peopleInvestigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales
- Where
- Llanelli
- Age
- 18 years to 80 years
- People
- 120
- Run by
- Hywel Dda Health Board
See details and how to joinNCT06914778 - No phaseTaking peopleHeart Failure in Patients With Diabetes: Cells, Crosstalk and Consequences
- Where
- Leeds
- Age
- 18 years and over
- People
- 600
- Run by
- University of Leeds
See details and how to joinNCT06774014 - No phaseTaking peopleA UK Registry for Metabolic and Bariatric Endoscopic Interventions
- Where
- London
- Age
- 18 years to 99 years
- People
- 300
- Run by
- Cleveland Clinic London
See details and how to joinNCT06305208 - No phaseTaking peopleChronotype of Patients With Diabetes and Effect on Glycaemic Control
- Where
- Leicester
- Age
- 18 years to 75 years
- People
- 3,447
- Run by
- University of Leicester
See details and how to joinNCT02973412 - No phaseTaking peoplePrevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
- Where
- Leicester
- Age
- 50 years to 75 years
- People
- 593
- Run by
- University of Leicester
See details and how to joinNCT03132129 - No phaseTaking peopleNational Registry of Rare Kidney Diseases
- Where
- Bristol
- People
- 35,000
- Run by
- UK Kidney Association
See details and how to joinNCT06065852 - No phaseTaking peopleWho Will Benefit From Bariatric Surgery for Diabetes?
- Where
- London
- Age
- 18 years to 80 years
- People
- 210
- Run by
- Imperial College London
See details and how to joinNCT03842475 - No phaseTaking peopleParaoxonase and HDL Qualities in Glycaemia and Inflammation
- Where
- Manchester
- Age
- 20 years to 75 years
- People
- 600
- Run by
- Manchester University NHS Foundation Trust
See details and how to joinNCT02169518 - No phaseTaking peopleThe European NAFLD Registry
- Where
- Birmingham, Cambridge, Gateshead, Hull, London, Newcastle upon Tyne, Nottingham, Oxford, Plymouth, Portsmouth
- Age
- 18 years to 100 years
- People
- 10,000 worldwide
- Run by
- Newcastle University
See details and how to joinNCT04442334 - No phaseTaking peopleEuropean Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
- Where
- Birmingham, Cambridge
- Age
- Up to 18 years
- People
- 2,000 worldwide
- Run by
- Cambridge University Hospitals NHS Foundation Trust
See details and how to joinNCT04190849 - No phaseTaking peopleNottingham Community Liver Biomarkers Cohort
- Where
- Nottingham
- Age
- 18 years and over
- People
- 2,000
- Run by
- University of Nottingham
See details and how to joinNCT02037867